News
Bayer & Kumquat Biosciences enter global license and collaboration to develop and commercialize Kumquat’s KRAS G12D inhibitor: Berlin, Germany Wednesday, August 13, 2025, 11:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback